127 related articles for article (PubMed ID: 14557591)
1. Response of recurrent anaplastic ependymoma to a combination of tamoxifen and isotretinoin.
Rojas-Marcos I; Calvet D; Janoray P; Delattre JY
Neurology; 2003 Oct; 61(7):1019-20. PubMed ID: 14557591
[No Abstract] [Full Text] [Related]
2. A case report of a recurrent intracranial ependymoma treated with temozolomide in remission 10 years after completing chemotherapy.
Rehman S; Brock C; Newlands ES
Am J Clin Oncol; 2006 Feb; 29(1):106-7. PubMed ID: 16462515
[No Abstract] [Full Text] [Related]
3. Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
Brandes AA; Tosoni A; Basso U; Reni M; Valduga F; Monfardini S; Amistà P; Nicolardi L; Sotti G; Ermani M
J Clin Oncol; 2004 Dec; 22(23):4779-86. PubMed ID: 15570079
[TBL] [Abstract][Full Text] [Related]
4. Response to temozolomide in supratentorial multifocal recurrence of malignant ependymoma.
Freyschlag CF; Tuettenberg J; Lohr F; Thomé C; Schmieder K; Seiz M
Anticancer Res; 2011 Mar; 31(3):1023-5. PubMed ID: 21498732
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin and temozolomide combination in the treatment of supratentorial anaplastic ependymoma.
Lombardi G; Pambuku A; Bellu L; Della Puppa A; Rumanò L; Gardiman MP; Pomerri F; Zagonel V
Chemotherapy; 2013; 59(3):176-80. PubMed ID: 24192541
[TBL] [Abstract][Full Text] [Related]
6. Regression of Recurrent High-Grade Glioma with Temozolomide, Dexamethasone, and Levetiracetam: Case Report and Review of the Literature.
Kumar A A; Abraham Koshy A
World Neurosurg; 2017 Dec; 108():990.e11-990.e16. PubMed ID: 28867318
[TBL] [Abstract][Full Text] [Related]
7. Interobserver variability in the radiological assessment of response to chemotherapy in glioma.
Vos MJ; Uitdehaag BM; Barkhof F; Heimans JJ; Baayen HC; Boogerd W; Castelijns JA; Elkhuizen PH; Postma TJ
Neurology; 2003 Mar; 60(5):826-30. PubMed ID: 12629241
[TBL] [Abstract][Full Text] [Related]
8. Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme.
Kilickap S; Oztoprak I; Yucel B
Acta Oncol; 2012 Apr; 51(4):544-6. PubMed ID: 22201408
[No Abstract] [Full Text] [Related]
9. Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide.
Stuplich M; Hadizadeh DR; Kuchelmeister K; Scorzin J; Filss C; Langen KJ; Schäfer N; Mack F; Schüller H; Simon M; Glas M; Pietsch T; Urbach H; Herrlinger U
J Clin Oncol; 2012 Jul; 30(21):e180-3. PubMed ID: 22689800
[No Abstract] [Full Text] [Related]
10. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
Sipos L; Vitanovics D; Afra D
Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of temozolomide treatment in patients with high-grade glioma.
Oshiro S; Tsugu H; Komatsu F; Ohmura T; Ohta M; Sakamoto S; Fukushima T; Inoue T
Anticancer Res; 2009 Mar; 29(3):911-7. PubMed ID: 19414327
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C
Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861
[TBL] [Abstract][Full Text] [Related]
13. Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study.
Jaeckle KA; Hess KR; Yung WK; Greenberg H; Fine H; Schiff D; Pollack IF; Kuhn J; Fink K; Mehta M; Cloughesy T; Nicholas MK; Chang S; Prados M;
J Clin Oncol; 2003 Jun; 21(12):2305-11. PubMed ID: 12805331
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease.
Egan G; Cervone KA; Philips PC; Belasco JB; Finlay JL; Gardner SL
Bone Marrow Transplant; 2016 Apr; 51(4):542-5. PubMed ID: 26726947
[TBL] [Abstract][Full Text] [Related]
15. Initial experience involving treatment and retreatment with carmustine wafers in combination with oral temozolomide: long-term survival in a child with relapsed glioblastoma multiforme.
Márquez-Rivas J; Ramirez G; Ollero-Ortiz A; Giménez-Pando J; Emmerich J; Quiroga-Cantero E; Rivas E; Gómez-González E
J Pediatr Hematol Oncol; 2010 Jul; 32(5):e202-6. PubMed ID: 20523247
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas.
Gururangan S; Cokgor L; Rich JN; Edwards S; Affronti ML; Quinn JA; Herndon JE; Provenzale JM; McLendon RE; Tourt-Uhlig S; Sampson JH; Stafford-Fox V; Zaknoen S; Early M; Friedman AH; Friedman HS
Neuro Oncol; 2001 Oct; 3(4):246-50. PubMed ID: 11584894
[TBL] [Abstract][Full Text] [Related]
17. Advantages and Disadvantages of Combined Chemotherapy with Carmustine Wafer and Bevacizumab in Patients with Newly Diagnosed Glioblastoma: A Single-Institutional Experience.
Akiyama Y; Kimura Y; Enatsu R; Mikami T; Wanibuchi M; Mikuni N
World Neurosurg; 2018 May; 113():e508-e514. PubMed ID: 29476996
[TBL] [Abstract][Full Text] [Related]
18. The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide.
Strowd RE; Abuali I; Ye X; Lu Y; Grossman SA
J Neurooncol; 2016 Mar; 127(1):165-71. PubMed ID: 26729269
[TBL] [Abstract][Full Text] [Related]
19. Malignant transformation of supratentorial clear cell ependymoma.
Kurimoto M; Nagai S; Hamada H; Tsuboi Y; Hayashi N; Kubota T; Endo S
Neuropathology; 2009 Jun; 29(3):299-302. PubMed ID: 18647267
[TBL] [Abstract][Full Text] [Related]
20. Re: B. Beuthien-Baumann, et al. Differentiation between recurrent tumor and radiation necrosis in a child with anaplastic ependymoma after chemotherapy and radiation therapy. Strahlenther Onkol 2003;179:819-22.
Kortmann RD; Timmermann B; Rutkowski S; Bamberg M
Strahlenther Onkol; 2004 Apr; 180(4):245. PubMed ID: 15057436
[No Abstract] [Full Text] [Related]
[Next] [New Search]
